Stay alert, beware of scamsters - know more

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open1,686
High1,688.8
Low1,666
Prev. Close1,687.8
Avg. Traded Price1,674.83
Volume45,137

MARKET DEPTH

info2
Total bid22203.00
Total ask26409.00
OrdersQtyBid
221667
1131666.8
1121666.7
171666.6
141666.2
AskQtyOrders
1668356
1668.1363
1668.916
166918
1669.118

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1666.005 hours ago
1688.803 hours ago
arrow

LOWER/UPPER CIRCUITS

1350.30
2025.30
arrow
Poly Medicure Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 13.44%, in the last year to ₹1,995.34 Cr. Its sector's average revenue growth for the last fiscal year was 19.48%.
notePrice to Earning Ratio,is 53.11, lower than its sector PE ratio of 64.93.
noteQuarterly Revenue,rose 21.25% YoY to ₹552.27 Cr. Its sector's average revenue growth YoY for the quarter was 24.71%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 48.58%
Net profit growth 5Y CAGR : 31.92%
Poly Medicure Ltd Top mutual funds holding
arrow

About Poly Medicure Ltd.

 

Poly Medicure Ltd. (Polymed) is a leading Indian manufacturer and exporter of medical devices, established in 1995. The company offers a diverse portfolio of 200+ products spanning infusion therapy, anaesthesia, oncology, urology, and gastroenterology, and exports to more than 125 countries, supported by state-of-the-art manufacturing facilities that adhere to international quality standards and certifications. Polymed manufactures and supplies devices across infusion therapy, oncology, anaesthesia and respiratory care, urology, gastroenterology, vascular access, surgery and wound drainage, dialysis and renal care, diagnostics, transfusion systems, veterinary medical devices and others. 

 

The company states it is the largest exporter of medical devices from India, with 70% of sales from exports to highly regulated developed markets like the EU, LATAM and South-East Asia; it is also among the top three IV cannula manufacturers globally and the first indigenous dialyzer manufacturer. Polymed’s footprint includes multiple units in Faridabad (Haryana), Haridwar (Uttarakhand) and Jaipur (SEZ, Rajasthan), along with overseas sites in Amaro, Italy; Laiyang–Qingdao, China; and Assuit, Egypt; the R&D Centre is located in Faridabad. As on the latest year, the company had 3 subsidiaries (and 3 step-subsidiaries) and employed 3,082 people.

 

Poly Medicure Ltd.’s Business Segments

 

  • Sales mix: Exports 70%; Domestic 30%.

 

Poly Medicure Ltd.’s Key Management

 

  • D. R. Mehta – Chairman

 

  • Himanshu Baid – Managing Director

 

  • Rishi Baid – Joint Managing Director

 

  • Naresh Vijayvargiya – Chief Financial Officer

 

  • Avinash Chandra – Company Secretary

 

These designations are as presented in the Annual Report’s statutory sections and financial statement sign-offs.

 

Latest Updates on Poly Medicure Ltd.

 

  • Product and technology: Recent launches include dialyzers, dialysis machines, safety Huber needles, PICC catheters, arterial and diagnostic catheters, guidewires, and pre-filled syringes; the company highlights that it is the first Indian firm to indigenously manufacture dialyzers.

 

  • R&D and intellectual property: Polymed reports being granted 334 patents globally (including in the USA, Europe, Brazil, Thailand, Japan and Australia) and maintains an R&D Centre equipped for rapid prototyping (3D printing), process validation and product customisation.

 

  • Recognitions: Recent honours include Best Healthcare Brands 2024 (ET Edge), Top 75 Industrial Innovative Company of the Year 2024 and Industrial Intellectual Property Awards 2024 (CII), Medical Devices Provider of the Year 2025 (Financial Express), and Healthcare Entrepreneur of the Year 2025 for the Managing Director, Himanshu Baid (Financial Express). The company also cites recognition such as The Next 500 Companies 2023 (Fortune India) and Best Company for Technology Innovation in Healthcare 2023 (ASSOCHAM).

 

  • Market engagement: The company participated in leading global exhibitions, including Arab Health (Dubai), Medica (Germany), Hospitalar (Brazil), FIME (Miami) and ExpoMed (Turkey).

 

personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

Poly Medicure Ltd has delivered -23.94% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,242.90 on 10 Jul 2025 and a 52-week low of ₹1,182.00 on 30 Mar 2026. It is currently trading at ₹1,669.80 as of 07 Jul 2026.

The all-time high (ATH) for Poly Medicure Ltd was ₹3,128.90, recorded on 01 Nov 2024. At the current price of ₹1,669.80, the stock is trading 46.63% below its all-time high. The all-time low recorded was ₹24.83 on 28 Dec 2011.

Poly Medicure Ltd has delivered a 73.80% absolute return over the past 5 years, equivalent to a CAGR of 11.69% per annum. The stock was priced at ₹960.76 in Jul 2021 and has risen to ₹1,669.80 as of 07 Jul 2026. An investment of ₹1,00,000 in Poly Medicure Ltd five years ago would be worth ₹1,73,800.00 today.

Yes,Poly Medicure Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 15.50 per share between FY2022 and FY2026, with the most recent dividend of ₹3.50 per share for May 26. At the current market price of ₹1,669.80, the trailing dividend yield of Poly Medicure Ltd stands at 6.50%.

As of 07 Jul 2026, the share price of Poly Medicure Ltd is ₹1,669.80 on the NSE and ₹1,672.00 on the BSE. The stock opened at ₹1,689.90, touched a high of ₹1,712.00 and a low of ₹1,665.90 during today's session.

Over the last 6 months, Poly Medicure Ltd has given a return of -6.27%. The stock was priced at ₹1,800.80 on 07 Jan 2026 and has Fallen to ₹1,669.80 as of 07 Jul 2026, a change of ₹131.00 per share.

For Q4 FY26, Poly Medicure Ltd reported: Revenue (Net Sales): ₹4430.15 Cr - Up 5.77% year-on-year from ₹4188.62 Cr in Q3 FY26. Net Income (PAT): ₹806.22 Cr - Up 2.86% year-on-year from ₹783.83 Cr in Q3 FY26.

Poly Medicure Ltd has delivered a return of 21.42% over the last 3 months. The stock was trading at ₹1,390.00 on 07 Apr 2026 and is currently at ₹1,669.80 as of 07 Jul 2026, reflecting a Gain of ₹279.80 per share over this period.

The intraday high for Poly Medicure Ltd on the NSE today (07 Jul 2026) was ₹1,712.00. This compares to the 52-week high of ₹2,242.90 recorded on 10 Jul 2025. Today's high was -23.67% below the 52-week high.

The intraday low for Poly Medicure Ltd on the NSE today was ₹1,665.90. The stock's 52-week low stands at ₹1,182.00, recorded on 30 Mar 2026. Today's low is 40.94% above the 52-week low, indicating the stock is trading well above its yearly lows.

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91